Question follow-through · 40092
Prostate Cancer: Hormone Treatments
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for his policies of the Institute of Cancer Research's report entitled Cost-utility analysis of adding abiraterone acetate plus prednisone/
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 20 Mar 2025
- Target answer date
- 25 Mar 2025
- Answer
- 25 Mar 2025 · 5 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Maternity Services: Anaesthetics · 24 Mar 2025
- Rare Cancers: Diagnosis · 24 Mar 2025
- Cancer: Screening · 24 Mar 2025
- Cancer: Children and Young People · 24 Mar 2025
- Prostate Cancer: Disadvantaged · 27 Mar 2025
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
20 Mar 2025
Question tabled
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for his policies of the Institute of Cancer Research's report entitled Cost-utility analysis of adding abiraterone acetate plus prednisone/
25 Mar 2025
Target answer date
Date supplied by the official written-questions record.
25 Mar 2025
Answer published
Abiraterone has a United Kingdom marketing authorisation for the treatment of metastatic hormone-relapsed prostate cancer before chemotherapy is indicated, and for castration-resistant metastatic prostate cancer previously treated with a docetaxel-contain...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Maternity Services: Anaesthetics
24 Mar 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the number of anaesthetists on maternity care.
Rare Cancers: Diagnosis
24 Mar 2025 · To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the late diagnosis of (a) rare and (b) less common cancers.
Cancer: Screening
24 Mar 2025 · To ask the Secretary of State for Health and Social Care, if he will take steps to increase the level of research into (a) multi-cancer early detection tests and (b) other innovative cancer screening methods.
Cancer: Children and Young People
24 Mar 2025 · To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential merits of implementing a target for at least 75% of children and young people to be (a) diagnosed and (b) have cancer ruled out within 10 days of the
Prostate Cancer: Disadvantaged
27 Mar 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of providing mobile PSA blood testing clinics in deprived communities on rates of early prostate cancer detection.
Prostate Cancer: Disadvantaged
27 Mar 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of implementing nurse-led mobile PSA blood testing clinics in deprived communities on (a) costs to and (b) staff productivity in the
Prostate Cancer: Ethnic Groups
27 Mar 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help increase research into the causes of prostate cancer in men of sub-Saharan African ancestry.
Health Services: Sportsgrounds
31 Mar 2025 · To ask the Secretary of State for Health and Social Care, what processes his Department undertook in its impact assessment into proposals for the Care Quality Commission to regulate sporting and cultural events; and if he will publish that work.
Hospitals: Discharges
23 Apr 2025 · To ask the Secretary of State for Health and Social Care, if he will make an estimate of the current number of hospital beds occupied by patients who are medically fit for discharge.
Pharmacy
28 Apr 2025 · To ask the Secretary of State for Health and Social Care, what his Department's timetable is for publishing the results of the consultation entitled Pharmacy supervision, which closed on 29 February 2024.
Pharmacy: Prescription Drugs
28 Apr 2025 · To ask the Secretary of State for Health and Social Care, what steps he is taking to prevent community pharmacies from operating at a financial loss when dispensing medicines for which the purchase price exceeds the NHS drug tariff reimbursement rate.
Pollution: Public Health
28 Apr 2025 · To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the potential impact of polluted rivers on public health.